Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine / Stephen Gottschalk, M.D. |
Innovation Grants |
2014 |
Texas |
Converting the Glioblastoma Multiforme Tumor-Associated Macrophage Phenotype |
The Johns Hopkins University School of Medicine / Alan D. Friedman, M.D. |
Innovation Grants |
2014 |
Maryland |
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD |
Young Investigator Grants |
2014 |
Maryland |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
Immunotherapy for Pediatric Atypical Teratoid/Rhabdoid Tumor |
Baylor College of Medicine / William Decker, PhD |
Reach Grants |
2013 |
Texas |
Accelerating Access to Cellular Therapies for the Treatment of Childhood Malignancies |
Seattle Children’s Hospital and Regional Medical Center / Julie Park, MD |
Phase I/II Infrastructure Grants |
2013 |
Washington |
Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies |
Baylor College of Medicine / Stephen Gottschalk, MD |
Innovation Grants |
2013 |
Texas |
Multispecific T Cells for Adoptive Immunotherapy of Pediatric High Grade Glioma (HGG) |
Baylor College of Medicine / Nabil Ahmed, MD, MSc |
Innovation Grants |
2013 |
Texas |
Pre-Clinical Testing of T cells Coded with CARs for DIPG |
University of Texas / Laurence Cooper, MD, PhD |
Innovation Grants |
2013 |
Texas |
Alex's Lemonade Stand Foundation Center of Excellence in Childhood Cancer Drug Development and Clinical Pharmacology at The Children's Hospital of Philadelphia
|
Children’s Hospital of Philadelphia / Frank Balis, MD - Scholar: Emily Blauel, MD |
Center of Excellence Grants |
2013 |
Pennsylvania |